169 related articles for article (PubMed ID: 8095549)
1. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.
Trachte GJ
J Pharmacol Exp Ther; 1993 Mar; 264(3):1227-33. PubMed ID: 8095549
[TBL] [Abstract][Full Text] [Related]
2. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1990 Nov; 255(2):497-503. PubMed ID: 1978729
[TBL] [Abstract][Full Text] [Related]
3. Neuromodulatory effect of the atrial natriuretic factor clearance receptor binding peptide, cANF(4-23)-NH2 in rabbit isolated vasa deferentia.
Johnson BG; Trachte GJ; Drewett JG
J Pharmacol Exp Ther; 1991 May; 257(2):720-6. PubMed ID: 1851836
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens.
Drewett JG; Trachte GJ; Marchand GR
J Pharmacol Exp Ther; 1989 Jan; 248(1):135-42. PubMed ID: 2536425
[TBL] [Abstract][Full Text] [Related]
5. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
[TBL] [Abstract][Full Text] [Related]
6. Activation of guanosine 3',5'-cyclic monophosphate (cGMP)-dependent protein kinase in rat vas deferens and distal colon is not accompanied by inhibition of contraction.
Patel AI; Hennan JK; Diamond J
J Pharmacol Exp Ther; 1997 Nov; 283(2):894-900. PubMed ID: 9353411
[TBL] [Abstract][Full Text] [Related]
7. Potassium channel inhibitors attenuate neuromodulatory effects of atrial natriuretic factor in the rabbit isolated vas deferens.
Kanwal S; Trachte GJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):117-23. PubMed ID: 7507992
[TBL] [Abstract][Full Text] [Related]
8. Cellular mechanisms of action of atrial natriuretic factor.
Gerzer R; Heim JM; Schütte B; Weil J
Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
10. Urodilatin attenuates sympathetic neurotransmission in the rabbit isolated vas deferens without activating guanylyl cyclase.
Trachte GJ
Life Sci; 2001 Nov; 69(24):2833-44. PubMed ID: 11720087
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.
Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ
J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539
[TBL] [Abstract][Full Text] [Related]
12. C-type natriuretic peptide neuromodulates independently of guanylyl cyclase activation.
Trachte GJ; Drewett JG
Hypertension; 1994 Jan; 23(1):38-43. PubMed ID: 7904255
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
14. Ontogeny of atrial natriuretic factor receptors and cyclic GMP response in rabbit renal glomeruli.
Castro R; Leake RD; Ervin MG; Ross MG; Fisher DA
Pediatr Res; 1991 Jul; 30(1):45-9. PubMed ID: 1653934
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of atrial natriuretic factor: clinical consequences.
Gerzer R; Weil J; Strom T; Müller T
Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.
Féthière J; De Léan A
Mol Pharmacol; 1991 Dec; 40(6):915-22. PubMed ID: 1684636
[TBL] [Abstract][Full Text] [Related]
17. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic factor stimulates exocrine pancreatic secretion in the rat through NPR-C receptors.
Sabbatini ME; Villagra A; Davio CA; Vatta MS; Fernandez BE; Bianciotti LG
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G929-37. PubMed ID: 12829435
[TBL] [Abstract][Full Text] [Related]
19. Natriuretic peptide-induced relaxation of myometrium from the pregnant guinea pig is not mediated by guanylate cyclase activation.
Carvajal JA; Aguan K; Thompson LP; Buhimschi IA; Weiner CP
J Pharmacol Exp Ther; 2001 Apr; 297(1):181-8. PubMed ID: 11259543
[TBL] [Abstract][Full Text] [Related]
20. Distinct properties of atrial natriuretic factor receptor subpopulations in epithelial and fibroblast cell lines.
Féthière J; Meloche S; Nguyen TT; Ong H; De Lean A
Mol Pharmacol; 1989 May; 35(5):584-92. PubMed ID: 2542756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
